Contact us for an appointment. 808-945-5433

Cardiovascular Pulmonary

Lung Disease (COPD) & Stem Cell Therapy

Written by Michael Pasquale January 30, 2020

Regeneration of lung tissue with stem cell therapy

This has been under study for the possible effects of stem cell therapy in regenerating the lung tissue damaged by smoking or chemical exposure. Also certain patients who have the disease may be predisposed to COPD, as they lack a certain enzyme since birth.

The patients suffer shortness of breath, asthma like symptoms, cough and sometimes even the ability to walk a flight of stairs. Treatments include bronchial dilators, steroids and exercise as well as supplemental oxygen. There are two types of COPD, chronic bronchitis and emphysema. Chronic bronchitis is characterized with a daily cough and a lot of mucous production. On the other hand, emphysema is characterized by destruction of the lung tissue. COPD patients typically have a combination of both chronic bronchitis and emphysema.

Anti inflammatory effects

Cellular therapy may offer hope to these patients due to the regenerative power of these cells. There is modulation of the immune system and an anti inflammatory effect. Our network has developed specific protocols under study to deploy mesenchymal stem cells derived from the patients own subcutaneous tissue and the fat layer. By using the patients own fat, we derive from the Stromal Vascular Fraction (SVF) or what may be termed “a stem cell broth” (which includes healing and growth factors). This is given to the patient under our specific study protocol.

At the Hawaii Stem Cell Treatment Center we use our network’s standardized SVF protocols for COPD. The entire procedure takes only a few hours and is performed under local anesthesia. Patients go home the same day of the procedure. Your results will be monitored and data recorded by a specialist in COPD.

If you are interested in further information and possibly to be a candidate for our study for COPD or lung disease please contact us.